INVO Fertility (IVF) Assets Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 64.05% |
| Jun 30, 2025 | 47.73% |
| Mar 31, 2025 | 57.87% |
| Dec 31, 2024 | 66.88% |
| Sep 30, 2024 | 12.44% |
| Jun 30, 2024 | -83.01% |
| Mar 31, 2024 | -83.09% |
| Dec 31, 2023 | 19.12% |
| Sep 30, 2023 | 116.08% |
| Jun 30, 2023 | 28.49% |
| Mar 31, 2023 | -33.74% |
| Dec 31, 2022 | 27.37% |
| Sep 30, 2022 | 18.48% |
| Jun 30, 2022 | 20.84% |
| Mar 31, 2022 | 32.06% |
| Dec 31, 2021 | 134.27% |
| Sep 30, 2021 | 103.62% |
| Jun 30, 2021 | 102.83% |
| Mar 31, 2021 | 221.14% |
| Dec 31, 2020 | 245.08% |
| Sep 30, 2020 | 103.49% |
| Jun 30, 2020 | 133.21% |
| Mar 31, 2020 | 70.14% |
| Dec 31, 2019 | 84.43% |
| Sep 30, 2019 | 87.43% |
| Jun 30, 2019 | 95.42% |
| Mar 31, 2019 | 85.45% |
| Dec 31, 2018 | 10.27% |
| Sep 30, 2018 | 66.54% |
| Jun 30, 2018 | 90.71% |
| Mar 31, 2018 | 39.33% |
| Dec 31, 2017 | 35.10% |
| Sep 30, 2017 | 25.43% |
| Jun 30, 2017 | 19.78% |
| Mar 31, 2017 | 19.20% |
| Dec 31, 2016 | 32.68% |
| Sep 30, 2016 | 50.19% |
| Jun 30, 2016 | 58.09% |
| Mar 31, 2016 | 67.63% |
| Dec 31, 2015 | 66.65% |
| Sep 30, 2015 | 12.39% |
| Jun 30, 2015 | 3.13% |
| Mar 31, 2015 | -3.89% |
| Dec 31, 2014 | -5.46% |
| Sep 30, 2014 | -8.95% |
| Jun 30, 2014 | -11.46% |
| Dec 31, 2013 | -12.19% |